Status:
UNKNOWN
DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer
Lead Sponsor:
Danish Head and Neck Cancer Group
Conditions:
Head and Neck Squamous Cell Carcinoma
Glottic T1
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To evaluate whether Transoral Laser Microsurgery (TLM) is non-inferior compared to Accelerated Radiotherapy (accRT) in the treatment of T1aN0M0 glottic SCC
Detailed Description
Since 2003 the Danish national standard treatment for T1aN0M0 glottic SCC has been accelerated RT (66Gy. 2 GY/fraction, 6 fractions/week). In 2012 cordectomy type I-III using TLM was introduced as an ...
Eligibility Criteria
Inclusion
- Danish patients aged ≥18 years diagnosed with a T1aN0M0 glottic squamous cell carcinoma (SCC)
Exclusion
- Unable to complete curative intended protocol treatment and/or planned follow up
- informed concent
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05289336
Start Date
September 1 2012
End Date
May 1 2022
Last Update
March 21 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, Denmark
2
Department of Experimental Clinical Oncology, Aarhus University Hospital
Aarhus, Denmark, 8000 C
3
Aarhus University Hospital
Aarhus, Denmark
4
Rigshospitalet
Copenhagen, Denmark